Innovative heart health testing comes to Walmart: Cardio Diagnostics and FMS partner up
In a move set to transform the landscape of cardiovascular health management, Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) has announced the availability of its AI-driven epigenetic-genetic blood tests, Epi+Gen CHD and PrecisionCHD, at a Walmart Supercenter in Round Lake Beach, Illinois, starting Q2 2024. This strategic deployment signifies a pivotal shift in the accessibility of advanced heart disease detection and prevention methods, making them available in a retail healthcare setting, a first-of-its-kind initiative in the northern suburb of Chicago in Lake County.
The collaboration between Cardio Diagnostics and Family Medicine Specialists (FMS) aims to expand the Heart Attack Prevention Initiative into the retail sector, democratizing access to clinical cardiovascular diagnostics. This initiative addresses the growing demand for high-quality healthcare services within the convenience of retail environments, as reported by AMN Healthcare, with an increasing number of Americans turning to retail clinics for care.
Meesha Dogan, Co-Founder, and CEO of Cardio Diagnostics, highlights the significance of this partnership, stating, “Our partnership with FMS to bring our tests to their Walmart locations is a game-changer in the field of cardiovascular health management.” This alliance is expected to revolutionize the availability of specialized heart disease services, making them more accessible to the general public and integrating them into the daily lives of Americans.
The initiative offers walk-in access to Cardio Diagnostics’ clinical blood tests at the Round Lake Beach Walmart location, empowering both employees and customers with the ability to assess their risk of heart attack and coronary heart disease with ease. This approach not only simplifies the process of obtaining crucial health assessments but also addresses the critical issue of increasing wait times for specialty care.
Jason Bellucci, President of Family Medicine Specialists, emphasizes the innovative nature of this collaboration, stating, “This partnership will enable us to bring advanced cardiac diagnostic tools directly into our retail healthcare clinic locations.” By leveraging the retail healthcare model, this initiative aims to enhance patient care and provide more advanced diagnostic solutions without the need for extensive infrastructure.
With cardiovascular disease rates on the rise and the average wait time for cardiology appointments extending significantly, the importance of making specialized tests more accessible cannot be overstated. The partnership between Cardio Diagnostics and FMS at Walmart locations represents a significant step forward in reducing wait times for cardiac assessments and expanding access to heart disease solutions in community settings.
Cardio Diagnostics stands at the forefront of AI-powered precision cardiovascular medicine, committed to improving the prevention, detection, and management of cardiovascular disease. Through its innovative approach and strategic partnerships, the company continues to drive advancements in healthcare accessibility and precision diagnostics, marking a new chapter in the fight against heart disease.